2009

1) Molimard M, Bamberger M, Vray M. Value of post-registration studies for reimbursement renewal. Therapie. 2009 May-Jun;64(3):203-13. Abstract

2) Launay O, Sadorge C, Jolly N, Poirier B, Béchet S, van der Vliet D, Seffer V, Fenner N, Dowling K, Giemza R, Johnson J, Ndiaye A, Vray M, Sansonetti P, Morand P, Poyart C, Lewis D, Gougeon ML. Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: results of a Phase 2, randomized, double-blind placebo-controlled trial. Vaccine. 2009 Feb 18;27(8):1184-91. Abstract

3) Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, Mahlaoui N, Debré M, Casanova JL, Dal Cortivo L, Madec Y, Hacein-Bey-Abina S, de Saint Basile G, de Villartay JP, Blanche S, Cavazzana-Calvo M, Fischer A. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009 Apr 23;113(17):4114-24. Abstract

4) Madec Y, Boufassa F, Avettand-Fenoel V, Hendou S, Melard A, Boucherit S, Surzyn J, Meyer L, Rouzioux C; ANRS SEROCO/HEMOCO Study Group. Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):19-26. Abstract

5) Madec Y, Szumilin E, Genevier C, Ferradini L, Balkan S, Pujades M, Fontanet A. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS. 2009 Apr 27;23(7):853-61. Abstract

6)  Paez Jimenez A, El-Din NS, El-Hoseiny M, El-Daly M, Abdel-Hamid M, El Aidi S, Sultan Y, El-Sayed N, Mohamed MK, Fontanet A. Community transmission of hepatitis B virus in Egypt: results from a case-control study in Greater Cairo. Int J Epidemiol. 2009 Jun;38(3):757-65. J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):486-91. Abstract

7) Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M. Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). Abstract

8) Micol R, Buchy P, Galimand J, Veasna D, Ferradini L, Balkan S, Guerin PJ, Martin PR, Fontanet A, Lortholary O, Rouzioux C, Leruez-Ville M. No association between human herpesvirus 6 reactivation and cryptococcosis in human immunodeficiency virus-infected patients. J Med Microbiol. 2009 Feb;58(Pt 2):276-7. Abstract

9) Martinez-Jéhanne V, du Merle L, Bernier-Fébreau C, Usein C, Gassama-Sow A, Wane AA, Gouali M, Damian M, Aïdara-Kane A, Germani Y, Fontanet A, Coddeville B, Guérardel Y, Le Bouguénec C. Role of deoxyribose catabolism in colonization of the murine intestine by pathogenic Escherichia coli strains. Infect Immun. 2009 Apr;77(4):1442-50. Abstract

10) Lefrère JJ, Shiboski C, Fontanet A, Murphy EL. Teaching transfusion medicine research in the francophone world. Transfus Clin Biol. 2009 Jul 27. Abstract

11) Laouénan C, Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Abdel-Hamid M, Rekacewicz C, Obach D, Fontanet A, Abel L. Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions. Hum Genet. 2009 Jul 23. Abstract

12) Kalberer U, Baud D, Fontanet A, Hohlfeld P, de Ziegler D. Birth records from Swiss married couples analyzed over the past 35 years reveal an aging of first-time mothers by 5.1 years while the interpregnancy interval has shortened. Fertil Steril. 2009 Jul 14. Abstract

13) Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA Dual mechanism for the impairment of IL-7 responses in HIV infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway. J Virol. 2009 Oct 28. Abstract

14) Jimenez AP, Mohamed MK, Eldin NS, Seif HA, El Aidi S, Sultan Y, Elsaid N, Rekacewicz C, El-Hoseiny M, El-Daly M, Abdel-Hamid M, Fontanet A. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS One. 2009 Sep 28;4(9):e7193. Abstract

15) El Makhzangy H, Esmat G, Said M, Elraziky M, Shouman S, Refai R, Rekacewicz C, Gad RR, Vignier N, Abdel-Hamid M, Zalata K, Bedossa P, Pol S, Fontanet A, Mohamed MK. Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4. J Med Virol. 2009 Sep;81(9):1576-83. Abstract

16) Leclerc PM, Matthews AP, Garenne ML. Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One. 2009;4(5):e5439. Abstract

17) Garenne M, Willie D, Maire B, Fontaine O, Eeckels R, Briend A, Van den Broeck J. Incidence and duration of severe wasting in two African populations. Public Health Nutr. 2009 Nov;12(11):1974-82. Abstract

18) Garenne M. Sex ratio at birth and family composition in sub-saharan Africa: inter-couple variations. J Biosoc Sci. 2009 May;41(3):399-407. Abstract

19) Garenne M. The sex composition of two-children families: heterogeneity and selection for the third child: comment on Stansfield and Carlton (2009). Hum Biol. 2009 Feb;81(1):97-100. Abstract

20) Rohani P, Breban R, Stallknecht DE, Drake JM. Environmental transmission of low pathogenicity avian influenza viruses and its implications for pathogen invasion. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10365-9. Abstract

21) Breban R, Napravnik S, Kahn J, Blower S. Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. BMC Public Health. 2009 Nov 18;9 Suppl 1:S11.Abstract

Mis à jour le 12/06/2014

Contact

Unité d'Epidémiologie des Maladies Emergentes


Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15


Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 7

Email: ueme@pasteur.fr

Où nous trouver ?

plan.jpg

Agenda

Tout l'agenda